Obiltoxaximab - Elusys Therapeutics
At a glance
- Drug Originator Elusys Therapeutics
- Drug Class Antibacterials; Antitoxins; Monoclonal antibodies
- Mechanism of Action Anthrax toxin inhibitors
- USA Patent Applicants ELUSYS THERAPEUTICS INC
- USA Patents 3
- BLAs 1
- International Patents 16

Disclaimer